Biblio

Author Title Type [ Year

]

Filters: Author is Helbig, Grzegorz [Clear All Filters]

2021

Masouridi-Levrat S, Olavarria E, Iacobelli S, Aljurf M, Morozova E, Niittyvuopio R, Sengeloev H, Reményi P, Helbig G, Browne P, et al. Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Pa. Bone Marrow Transplant. 2021.

2020

Gołos A, Gil L, Puła B, Boguradzki P, Hałaburda K, Sawicki W, Sobczyk-Kruszelnicka M, Helbig G, Dybko J, Jurczyszyn A, et al. Allogeneic hematopoietic cell transplantation for multiple myeloma: A retrospective analysis of the Polish Myeloma Group. Adv Med Sci. 2020;65(2):429-436.

2012

Kopińska A, Helbig G, Frankiewicz A, Grygoruk-Wiśniowska I, Kyrcz-Krzemień S. Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation. Contemp Oncol (Pozn). 2012;16(3):215-217.